The post COVID bump up in demand is showing signs of moderation.
Total sales reached Rs 60,000 crore in the September 2024 quarter
The IPO values NTPC Green Energy at Rs 91,000 crore to 1 lakh crore, generating value for NTPC investors and setting the to-be-listed company on an independent path
The company has lowered revenue guidance for the full year as order wins remain sluggish
Total works in hand rose to Rs 1.43 lakh crore in November 2024 from Rs 50,500 crore in the year ago period.
The country’s steady, healthy steel demand growth, preference for domestic capacity, states’ drive for value addition and a healthy balance sheet situation make it an attractive destination
The conservative approach to lending with focus on asset quality is a big positive
After subdued Q1 and Q2, hopes now are pinned on recovery in H2 FY25
The only segment which saw a declining trend was commercial vehicles. Companies say that the government's emphasis on infrastructure, construction, and mining activities provide further hope for the auto sector
Loan growth strong, deposit mix improving, steady interest margin, and good asset quality
Himachal Pradesh, which hosts close to a quarter of India’s large operating hydro power plants, is facing low reservoir water levels
Suzlon’s wind turbine generator emerges as one of the most in demand models
Project developers are attaching counterparty risk premium to power sale contracts with states amid delays in payments
The quarterly performance was a mixed bag with a reassuring commentary
The company is focusing on optimising portfolio and streamlining capacities
Electricity generation and usage in India is estimated to exceed that in the European Union by 2050
The third quarter should be relatively better for HCL’s software business and Q4 should be good too
Volumes contributed just 0.8 percentage points to Indian pharmaceutical market growth in 12 months to September 2024
Order inflows at TCS declined in last two quarters while Accenture reported strong growth in bookings
The long-term prospects for Manappuram’s non-gold businesses are unclear at the moment
With the ramp-up of new projects and fresh order wins, the current growth trajectory should continue into FY25-26
The company has extended its agreement with Philogen to commercialise an immunotherapy drug globally
After the integration of Keimed with AHL, Advent will hold a 12.1% stake in the combined entity.
Resolution of stressed thermal power plants is picking up pace on rising electricity demand and improving operating metrics
If at all a correction, it is likely to be a shallow one thanks to the support of domestic liquidity